Quantcast

Latest diabetes care Stories

2014-05-01 08:33:38

- Announces revenues of $2.072 billion, an increase of 3.6 percent, or 5.1 percent on a foreign currency-neutral basis. FRANKLIN LAKES, N.J., May 1, 2014 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today reported quarterly revenues of $2.072 billion for the second fiscal quarter ended March 31, 2014, representing an increase of 3.6 percent from the prior-year period, or 5.1 percent on a foreign currency-neutral basis....

2014-04-23 12:29:24

Program Also Led to Better Blood Glucose Control and Greater Reductions in Heart Disease Risk Factors; Jenny Craig for Type 2 Now Available to Consumers CARLSBAD, Calif., April 23, 2014 /PRNewswire/ -- Study Highlights: -- After one year, Jenny Craig participants lost more than three times as much weight as the Usual Care group. -- Study participants following Jenny Craig's lower carbohydrate menu significantly reduced their HbA1c levels from 7.3% to 6.6%, while...

2014-04-16 12:29:41

CHARLOTTE, N.C., April 16, 2014 /PRNewswire/ -- On April 10, 2014 the U.S. Food & Drug Administration (FDA) issued a "Closeout" letter to Prodigy Diabetes Care to formally conclude the regulatory action that resulted in a Warning Letter on February 22, 2013. Since the original site inspection of Prodigy in March 2012, and in response to the February 2013 letter, Prodigy has worked with the FDA to address and correct the issues identified through that inspection. The FDA Atlanta...

2014-04-15 08:28:57

Sales of $18.1 Billion increased 3.5% Versus 2013 First Quarter; NEW BRUNSWICK, N.J., April 15, 2014 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) today announced sales of $18.1 billion for the first quarter of 2014, an increase of 3.5% as compared to the first quarter of 2013. Operational results increased 5.3% and the negative impact of currency was 1.8%. Domestic sales increased 2.2%. International sales increased 4.5%, reflecting operational growth of 7.9% and a...

2014-04-08 15:47:41

Researchers at the University of Adelaide have discovered that a common treatment for people with type 2 diabetes could cause longer-than-normal periods of the low blood sugar reaction hypoglycemia, which may result in increased health risks to people with diabetes. The treatment is the use of the peptide GLP-1 (glucagon-like peptide 1) in combination with insulin, which is now used throughout the world as a standard therapy for patients with type 2 diabetes. A team of researchers at...

2014-04-08 12:31:28

NOORDWIJK, The Netherlands, April 8, 2014 /PRNewswire/ -- Urgent need to mobilise and involve people with diabetes in partnership efforts to face the challenges of the diabetes pandemic Link to the multimedia release [http://www.novonordisk.com/press/press-releases/DAWN2-amhg.asp ] Participants at the 5th International DAWN(TM) Summit (Diabetes Attitudes Wishes and Needs) today pledged to work together to make person-centred diabetes care a reality for the 382...

2014-03-28 04:21:53

BAGSVAERD, Denmark, March 28, 2014 /PRNewswire/ -- Novo Nordisk today announces the launch of 'Cities Changing Diabetes', an ambitious new partnership programme to fight the urban diabetes challenge. The 'Cities Changing Diabetes' programme will first be launched in Mexico City with other cities in North America, Europe and Asia soon to follow. To view the Multimedia News Release, please click:...

2014-03-26 11:27:31

People with type 2 diabetes who report good self-management behavior have a reduced mortality risk. This was the result of a population-based study conducted by scientists at Helmholtz Zentrum München emphasizing the great importance of patient behavior in the diabetes treatment process. These findings were published in the journal ‘Diabetes Care’. Scientists of the Institute of Health Economics and Health Care Management (IGM) and of the Institute of Epidemiology II (EPI II) at...

2014-03-18 12:30:53

-- Results Add to Evidence that SPLENDA® is Safe for People with Diabetes - FT. WASHINGTON, Pa., March 18, 2014 /PRNewswire-USNewswire/ -- Consuming sucralose in a drink is shown to have the same effect as water on a person's sugar and insulin levels, according to a study reported in Diabetes Care, a journal of the American Diabetes Association(1). Sucralose is the no calorie sweetening ingredient in SPLENDA® Sweetener Products....

2014-03-07 23:21:46

Brock Will Share His Personal Account of Managing His Condition April 10 in Princeton, N.J., at Patient-Centered Diabetes Care: Putting Theory into Practice, sponsored by The American Journal of Managed Care PLAINSBORO, N.J. (PRWEB) March 07, 2014 Baseball Hall of Famer Lou Brock, best known as one of the game’s most prolific base stealers, will share his story of dealing with diabetes at an April conference, hosted by The American Journal of Managed Care, devoted to bringing the recent...


Latest diabetes care Reference Libraries

Diabetes Care
2012-05-12 21:41:27

Diabetes Care is a peer-reviewed medical journal established in 1978 and published monthly by the American Diabetes Association. It covers research in the following five categories: clinical care/education/nutrition/psychosocial research; epidemiology/health services research; emerging treatments and technologies; pathophysiology/complications; and cardiovascular and metabolic risk. The journal also publishes clinically relevant review articles, letters to the editor, and commentaries....

More Articles (1 articles) »
Word of the Day
omphalos
  • The navel or umbilicus.
  • In Greek archaeology: A central boss, as on a shield, a bowl, etc.
  • A sacred stone in the temple of Apollo at Delphi, believed by the Greeks to mark the 'navel' or exact center-point of the earth.
'Omphalos' comes from the ancient Greek.
Related